aluates Reports

$ 0.0

Automative

Global Molecular Diagnostics Cancer Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-34N2713

Global Molecular Diagnostics Cancer Market Insights Forecast to 2028

BUY CHAPTERS

Global Molecular Diagnostics Cancer Market Research Report 2024

Code: QYRE-Auto-34N2713

Report

February 2024

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Molecular Diagnostics Cancer Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Molecular Diagnostics Cancer Market

A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.

The global Molecular Diagnostics Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Cancer.

Report Scope

The Molecular Diagnostics Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Diagnostics Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Molecular Diagnostics Cancer Market Report

Report Metric	Details
Report Name	Molecular Diagnostics Cancer Market
CAGR	5%
Segment by Type	Pharmacogenomic Diagnosis Liquid Biopsy Other
Segment by Application	Respiratory Cancer Cancer of Digestive System Cancer of Urinary System Cancer of Circulatory System Motor System Cancer Reproductive System Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Diagnostics Cancer Market report?

Ans: The main players in the Molecular Diagnostics Cancer Market are Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex

What are the Application segmentation covered in the Molecular Diagnostics Cancer Market report?

Ans: The Applications covered in the Molecular Diagnostics Cancer Market report are Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System, Motor System Cancer, Reproductive System Cancer, Other

What are the Type segmentation covered in the Molecular Diagnostics Cancer Market report?

Ans: The Types covered in the Molecular Diagnostics Cancer Market report are Pharmacogenomic Diagnosis, Liquid Biopsy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Pharmacogenomic Diagnosis

1.2.3 Liquid Biopsy

1.2.4 Other

1.3 Market by Application

1.3.1 Global Molecular Diagnostics Cancer Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Respiratory Cancer

1.3.3 Cancer of Digestive System

1.3.4 Cancer of Urinary System

1.3.5 Cancer of Circulatory System

1.3.6 Motor System Cancer

1.3.7 Reproductive System Cancer

1.3.8 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Diagnostics Cancer Market Perspective (2019-2030)

2.2 Molecular Diagnostics Cancer Growth Trends by Region

2.2.1 Global Molecular Diagnostics Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2019-2024)

2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2025-2030)

2.3 Molecular Diagnostics Cancer Market Dynamics

2.3.1 Molecular Diagnostics Cancer Industry Trends

2.3.2 Molecular Diagnostics Cancer Market Drivers

2.3.3 Molecular Diagnostics Cancer Market Challenges

2.3.4 Molecular Diagnostics Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Diagnostics Cancer Players by Revenue

3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2019-2024)

3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue

3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio

3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2023

3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served

3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service

3.7 Date of Enter into Molecular Diagnostics Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnostics Cancer Breakdown Data by Type

4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2019-2024)

4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2025-2030)

5 Molecular Diagnostics Cancer Breakdown Data by Application

5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2019-2024)

5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Molecular Diagnostics Cancer Market Size (2019-2030)

6.2 North America Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Molecular Diagnostics Cancer Market Size by Country (2019-2024)

6.4 North America Molecular Diagnostics Cancer Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Diagnostics Cancer Market Size (2019-2030)

7.2 Europe Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Molecular Diagnostics Cancer Market Size by Country (2019-2024)

7.4 Europe Molecular Diagnostics Cancer Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2019-2030)

8.2 Asia-Pacific Molecular Diagnostics Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2019-2024)

8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Molecular Diagnostics Cancer Market Size (2019-2030)

9.2 Latin America Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Molecular Diagnostics Cancer Market Size by Country (2019-2024)

9.4 Latin America Molecular Diagnostics Cancer Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2019-2030)

10.2 Middle East & Africa Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2019-2024)

10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Molecular Diagnostics Cancer Introduction

11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Danaher

11.2.1 Danaher Company Detail

11.2.2 Danaher Business Overview

11.2.3 Danaher Molecular Diagnostics Cancer Introduction

11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.2.5 Danaher Recent Development

11.3 Siemens

11.3.1 Siemens Company Detail

11.3.2 Siemens Business Overview

11.3.3 Siemens Molecular Diagnostics Cancer Introduction

11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.3.5 Siemens Recent Development

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Detail

11.4.2 Abbott Laboratories Business Overview

11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction

11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.4.5 Abbott Laboratories Recent Development

11.5 ICON Plc

11.5.1 ICON Plc Company Detail

11.5.2 ICON Plc Business Overview

11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction

11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.5.5 ICON Plc Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction

11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.6.5 AstraZeneca Recent Development

11.7 MDxHealth

11.7.1 MDxHealth Company Detail

11.7.2 MDxHealth Business Overview

11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction

11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.7.5 MDxHealth Recent Development

11.8 Invitae

11.8.1 Invitae Company Detail

11.8.2 Invitae Business Overview

11.8.3 Invitae Molecular Diagnostics Cancer Introduction

11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.8.5 Invitae Recent Development

11.9 PlexBio

11.9.1 PlexBio Company Detail

11.9.2 PlexBio Business Overview

11.9.3 PlexBio Molecular Diagnostics Cancer Introduction

11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.9.5 PlexBio Recent Development

11.10 Thermo Fisher Scientific

11.10.1 Thermo Fisher Scientific Company Detail

11.10.2 Thermo Fisher Scientific Business Overview

11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction

11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.10.5 Thermo Fisher Scientific Recent Development

11.11 Guardant Health

11.11.1 Guardant Health Company Detail

11.11.2 Guardant Health Business Overview

11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction

11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.11.5 Guardant Health Recent Development

11.12 Biocartis

11.12.1 Biocartis Company Detail

11.12.2 Biocartis Business Overview

11.12.3 Biocartis Molecular Diagnostics Cancer Introduction

11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.12.5 Biocartis Recent Development

11.13 Bio-Techne

11.13.1 Bio-Techne Company Detail

11.13.2 Bio-Techne Business Overview

11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction

11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.13.5 Bio-Techne Recent Development

11.14 Merck

11.14.1 Merck Company Detail

11.14.2 Merck Business Overview

11.14.3 Merck Molecular Diagnostics Cancer Introduction

11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.14.5 Merck Recent Development

11.15 Foundation Medicine

11.15.1 Foundation Medicine Company Detail

11.15.2 Foundation Medicine Business Overview

11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction

11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.15.5 Foundation Medicine Recent Development

11.16 10X Genomics

11.16.1 10X Genomics Company Detail

11.16.2 10X Genomics Business Overview

11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction

11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.16.5 10X Genomics Recent Development

11.17 Biodesix

11.17.1 Biodesix Company Detail

11.17.2 Biodesix Business Overview

11.17.3 Biodesix Molecular Diagnostics Cancer Introduction

11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.17.5 Biodesix Recent Development

11.18 CytoTrack

11.18.1 CytoTrack Company Detail

11.18.2 CytoTrack Business Overview

11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction

11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.18.5 CytoTrack Recent Development

11.19 GenomOncology

11.19.1 GenomOncology Company Detail

11.19.2 GenomOncology Business Overview

11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction

11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.19.5 GenomOncology Recent Development

11.20 Luminex

11.20.1 Luminex Company Detail

11.20.2 Luminex Business Overview

11.20.3 Luminex Molecular Diagnostics Cancer Introduction

11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2019-2024)

11.20.5 Luminex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Pharmacogenomic Diagnosis

Table 3. Key Players of Liquid Biopsy

Table 4. Key Players of Other

Table 5. Global Molecular Diagnostics Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Molecular Diagnostics Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Molecular Diagnostics Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Molecular Diagnostics Cancer Market Share by Region (2019-2024)

Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Molecular Diagnostics Cancer Market Share by Region (2025-2030)

Table 11. Molecular Diagnostics Cancer Market Trends

Table 12. Molecular Diagnostics Cancer Market Drivers

Table 13. Molecular Diagnostics Cancer Market Challenges

Table 14. Molecular Diagnostics Cancer Market Restraints

Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Molecular Diagnostics Cancer Market Share by Players (2019-2024)

Table 17. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2023)

Table 18. Ranking of Global Top Molecular Diagnostics Cancer Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Molecular Diagnostics Cancer Product Solution and Service

Table 22. Date of Enter into Molecular Diagnostics Cancer Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2019-2024)

Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2025-2030)

Table 28. Global Molecular Diagnostics Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2019-2024)

Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2025-2030)

Table 32. North America Molecular Diagnostics Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Molecular Diagnostics Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Molecular Diagnostics Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Molecular Diagnostics Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Molecular Diagnostics Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 47. Roche Company Detail

Table 48. Roche Business Overview

Table 49. Roche Molecular Diagnostics Cancer Product

Table 50. Roche Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Danaher Company Detail

Table 53. Danaher Business Overview

Table 54. Danaher Molecular Diagnostics Cancer Product

Table 55. Danaher Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 56. Danaher Recent Development

Table 57. Siemens Company Detail

Table 58. Siemens Business Overview

Table 59. Siemens Molecular Diagnostics Cancer Product

Table 60. Siemens Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 61. Siemens Recent Development

Table 62. Abbott Laboratories Company Detail

Table 63. Abbott Laboratories Business Overview

Table 64. Abbott Laboratories Molecular Diagnostics Cancer Product

Table 65. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 66. Abbott Laboratories Recent Development

Table 67. ICON Plc Company Detail

Table 68. ICON Plc Business Overview

Table 69. ICON Plc Molecular Diagnostics Cancer Product

Table 70. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 71. ICON Plc Recent Development

Table 72. AstraZeneca Company Detail

Table 73. AstraZeneca Business Overview

Table 74. AstraZeneca Molecular Diagnostics Cancer Product

Table 75. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 76. AstraZeneca Recent Development

Table 77. MDxHealth Company Detail

Table 78. MDxHealth Business Overview

Table 79. MDxHealth Molecular Diagnostics Cancer Product

Table 80. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 81. MDxHealth Recent Development

Table 82. Invitae Company Detail

Table 83. Invitae Business Overview

Table 84. Invitae Molecular Diagnostics Cancer Product

Table 85. Invitae Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 86. Invitae Recent Development

Table 87. PlexBio Company Detail

Table 88. PlexBio Business Overview

Table 89. PlexBio Molecular Diagnostics Cancer Product

Table 90. PlexBio Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 91. PlexBio Recent Development

Table 92. Thermo Fisher Scientific Company Detail

Table 93. Thermo Fisher Scientific Business Overview

Table 94. Thermo Fisher Scientific Molecular Diagnostics Cancer Product

Table 95. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 96. Thermo Fisher Scientific Recent Development

Table 97. Guardant Health Company Detail

Table 98. Guardant Health Business Overview

Table 99. Guardant Health Molecular Diagnostics Cancer Product

Table 100. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 101. Guardant Health Recent Development

Table 102. Biocartis Company Detail

Table 103. Biocartis Business Overview

Table 104. Biocartis Molecular Diagnostics Cancer Product

Table 105. Biocartis Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 106. Biocartis Recent Development

Table 107. Bio-Techne Company Detail

Table 108. Bio-Techne Business Overview

Table 109. Bio-Techne Molecular Diagnostics Cancer Product

Table 110. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 111. Bio-Techne Recent Development

Table 112. Merck Company Detail

Table 113. Merck Business Overview

Table 114. Merck Molecular Diagnostics Cancer Product

Table 115. Merck Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 116. Merck Recent Development

Table 117. Foundation Medicine Company Detail

Table 118. Foundation Medicine Business Overview

Table 119. Foundation Medicine Molecular Diagnostics Cancer Product

Table 120. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 121. Foundation Medicine Recent Development

Table 122. 10X Genomics Company Detail

Table 123. 10X Genomics Business Overview

Table 124. 10X Genomics Molecular Diagnostics Cancer Product

Table 125. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 126. 10X Genomics Recent Development

Table 127. Biodesix Company Detail

Table 128. Biodesix Business Overview

Table 129. Biodesix Molecular Diagnostics Cancer Product

Table 130. Biodesix Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 131. Biodesix Recent Development

Table 132. CytoTrack Company Detail

Table 133. CytoTrack Business Overview

Table 134. CytoTrack Molecular Diagnostics Cancer Product

Table 135. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 136. CytoTrack Recent Development

Table 137. GenomOncology Company Detail

Table 138. GenomOncology Business Overview

Table 139. GenomOncology Molecular Diagnostics Cancer Product

Table 140. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 141. GenomOncology Recent Development

Table 142. Luminex Company Detail

Table 143. Luminex Business Overview

Table 144. Luminex Molecular Diagnostics Cancer Product

Table 145. Luminex Revenue in Molecular Diagnostics Cancer Business (2019-2024) & (US$ Million)

Table 146. Luminex Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Diagnostics Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Molecular Diagnostics Cancer Market Share by Type: 2023 VS 2030

Figure 3. Pharmacogenomic Diagnosis Features

Figure 4. Liquid Biopsy Features

Figure 5. Other Features

Figure 6. Global Molecular Diagnostics Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Molecular Diagnostics Cancer Market Share by Application: 2023 VS 2030

Figure 8. Respiratory Cancer Case Studies

Figure 9. Cancer of Digestive System Case Studies

Figure 10. Cancer of Urinary System Case Studies

Figure 11. Cancer of Circulatory System Case Studies

Figure 12. Motor System Cancer Case Studies

Figure 13. Reproductive System Cancer Case Studies

Figure 14. Other Case Studies

Figure 15. Molecular Diagnostics Cancer Report Years Considered

Figure 16. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Molecular Diagnostics Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Molecular Diagnostics Cancer Market Share by Region: 2023 VS 2030

Figure 19. Global Molecular Diagnostics Cancer Market Share by Players in 2023

Figure 20. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2023

Figure 22. North America Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 24. United States Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 28. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Molecular Diagnostics Cancer Market Share by Region (2019-2030)

Figure 36. China Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 44. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Molecular Diagnostics Cancer Market Share by Country (2019-2030)

Figure 48. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 51. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 52. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 53. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 54. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 55. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 56. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 57. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 58. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 60. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 61. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 62. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 63. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 64. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 65. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 66. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 67. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 68. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 69. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Molecular Diagnostics Cancer Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-34N2713

Global Molecular Diagnostics Cancer Market Research Report 2024

FEATURED COMPANIES

Molecular Diagnostics Cancer Market Size

Molecular Diagnostics Cancer Market

Report Scope

Scope of Molecular Diagnostics Cancer Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Molecular Diagnostics Cancer Market report?

What are the Application segmentation covered in the Molecular Diagnostics Cancer Market report?

What are the Type segmentation covered in the Molecular Diagnostics Cancer Market report?

FEATURED COMPANIES